Sakakibara R, Hashida K, Kitahara T, Ishiguro M
Department of Biochemistry, School of Clinical Pharmaceutical Sciences, Nagasaki University.
J Biochem. 1992 Mar;111(3):325-30. doi: 10.1093/oxfordjournals.jbchem.a123757.
We have reported previously [Sakakibara, et al. (1991) Chem. Pharm. Bull. 39, 146-149] that a protein purified from a partially purified pharmaceutical preparation of human chorionic gonadotropin (a urinary protein preparation from pregnant women) is a unique nonsecretory ribonuclease (RNase)-like protein on the basis of its amino terminal sequence homology. We purified the protein further from the same materials by gel filtration and reversed-phase column chromatographies with RNase activity as an index. The purified protein was designated RNase UpI-2. The catalytic activity and its sensitivity to inhibition by divalent cations suggest that the protein is related to nonsecretory RNase. The estimated molecular weight of RNase UpI-2 (38 kDa) by sodium dodecyl sulfate-polyacrylamide gel electrophoresis was significantly higher than that of urinary nonsecretory RNases (13 to 19 kDa) reported so far. After trifluoromethanesulfonic acid treatment, the molecular weight of RNase UpI-2 was reduced and approached that of nonsecretory RNase, which indicated that the protein contains a significant amount of carbohydrate (approximately 50%). RNase UpI-2 was immunoreactive with antibodies to a nonsecretory RNase, RNAase 1 [Yasuda et al. (1988) Biochim. Biophys. Acta 965, 185-194]. By immunoblot analysis of the protein freshly prepared from various urine samples, it was shown that a considerable amount of RNase UpI-2 is present in urine of pregnant women, but only a trace of RNase UpI-2, if any, was detected in urine of nonpregnant women and men. These results suggest the possibility that RNase UpI-2 may have been formed via a specific protein modification in pregnant women.
我们之前已经报道过[Sakakibara等人(1991年),《化学与药学通报》39卷,第146 - 149页],从人绒毛膜促性腺激素的部分纯化药物制剂(孕妇尿液蛋白制剂)中纯化得到的一种蛋白质,基于其氨基末端序列同源性,是一种独特的非分泌型核糖核酸酶(RNase)样蛋白质。我们以RNase活性为指标,通过凝胶过滤和反相柱色谱法从相同材料中进一步纯化该蛋白质。纯化后的蛋白质被命名为RNase UpI - 2。其催化活性及其对二价阳离子抑制的敏感性表明该蛋白质与非分泌型RNase有关。通过十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳估计的RNase UpI - 2分子量(38 kDa)明显高于迄今报道的尿液非分泌型RNase的分子量(13至19 kDa)。经三氟甲磺酸处理后,RNase UpI - 2的分子量降低并接近非分泌型RNase的分子量,这表明该蛋白质含有大量碳水化合物(约50%)。RNase UpI - 2与非分泌型RNase RNAase 1的抗体具有免疫反应性[Yasuda等人(1988年),《生物化学与生物物理学报》965卷,第185 - 194页]。通过对从各种尿液样本新鲜制备的蛋白质进行免疫印迹分析表明,孕妇尿液中存在相当数量的RNase UpI - 2,但在非孕妇和男性尿液中仅检测到痕量的RNase UpI - 2(如果有的话)。这些结果表明RNase UpI - 2可能是通过孕妇体内特定的蛋白质修饰形成的。